President’s Cancer Panel Goals and Recommendations
| Goal/Recommendation | Responsible Stakeholder(s) |
|---|---|
| Goal 1: Improve and Align Cancer Screening Communication | |
| Recommendation 1.1: Develop effective communications about cancer screening that reach all populations. | |
| Develop and implement communications campaigns focused on cancer screening. |
Centers for Disease Control and Prevention State health departments National advocacy organizations (e.g., American Cancer Society) Healthcare systems Community organizations |
| Recommendation 1.2: Expand and strengthen National Cancer Roundtables that include a focus on cancer screening. | |
| Create National Cancer Roundtables for breast cancer and cervical cancer that include a strong focus on screening. Increase financial support for the National Colorectal Cancer Roundtable and National Lung Cancer Roundtable. |
American Cancer Society Centers for Disease Control and Prevention |
| Make health equity and alignment of messaging about cancer screening and cancer screening guidelines a high priority for National Roundtables. | National Roundtables |
| Goal 2: Facilitate Equitable Access to Cancer Screening | |
| Recommendation 2.1: Provide and sustainably fund community-oriented outreach and support services to promote appropriate screening and follow-up care. | |
| Establish community health worker programs to reach people in communities and ensure those eligible receive appropriate and timely cancer screening and follow-up care. |
Healthcare systems Health plans State health departments |
| Establish sustainable funding for community health worker programs to ensure they meet their full potential. |
Healthcare systems Health plans State health departments |
| Provide training, directly or through partnerships with outside organizations, to ensure community health workers have the knowledge and skills necessary to do their jobs. |
Healthcare systems Health plans State health departments |
| Recommendation 2.2: Increase access to self-sampling for cancer screening. | |
| Promote stool-based tests as an option for colorectal cancer screening. | Healthcare providers |
| Distribute stool-based tests to individuals due for colorectal cancer screening as part of a systematic effort to increase appropriate screening. |
Healthcare systems Health plans |
| Participate in validation efforts and pursue regulatory approval for HPV self-sampling strategies. | HPV test manufacturers |
| Prioritize review of the evidence supporting HPV self-sampling. | U.S. Food and Drug Administration |
| Goal 3: Strengthen Workforce Collaborations to Support Cancer Screening and Risk Assessment | |
| Recommendation 3.1: Empower healthcare team members to support screening. | |
| Create systems that allow all healthcare team members to promote and implement cancer screening programs or practices. | Healthcare systems |
| Modify requirements to allow nonphysician members of physician-led teams to conduct shared decision-making for lung cancer screening. | Centers for Medicare & Medicaid Services |
| Recommendation 3.2: Expand access to genetic testing and counseling for cancer risk assessment. | |
| Enable providers to offer genetic testing with informed consent. Eliminate requirements for pretest counseling by a certified genetic counselor or medical geneticist for coverage of genetic testing. | Health plans |
| Expand provider training and education on genetics, genetic testing, and interpretation of genetic testing results. |
Medical training and residency programs Professional societies Guideline makers |
| Allow CMS to recognize genetic counselors as healthcare providers. | U.S. Congress |
| Goal 4: Create Health Information Technology that Promotes Appropriate Cancer Risk Assessment and Screening | |
| Recommendation 4.1: Create computable versions of cancer screening and risk assessment guidelines. | |
| Fund development of computable guidelines for cancer risk assessment and screening. |
Agency for Healthcare Research and Quality Centers for Disease Control and Prevention National Institutes of Health Private research funding organizations (e.g., American Cancer Society) |
| Consider investment in dedicated programs to support creation of computable guidelines relevant to risk assessment, screening, and follow-up care for cancer and other diseases. |
Centers for Disease Control and Prevention Agency for Healthcare Research and Quality |
| Recommendation 4.2: Create and deploy effective clinical decision support tools for cancer risk assessment and screening. | |
| Prioritize support for development and evaluation of standards-based, interoperable clinical decision support for cancer risk assessment and screening. |
EHR vendors Healthcare systems Agency for Healthcare Research and Quality Centers for Disease Control and Prevention National Institutes of Health Private research funding organizations |
| Include clinical decision support for cancer risk assessment and screening in standard EHR systems and make it easy for clinical decision support developed by others to be integrated into EHR systems. | EHR vendors |
CMS = Centers for Medicare & Medicaid Services; EHR = electronic health record; FDA = U.S. Food and Drug Administration; HPV = human papillomavirus
